Foamix Pharmaceuticals Ltd. (FOMX)

HP: www.foamix.co.il/


Foamix Pharmaceuticals is a specialty pharmaceutical company, committed to addressing unmet needs of patients by bringing innovative solutions to the field of dermatology. The company is in late-stage clinical development of two lead products based on the company"s first-in-class topical Minocycline Foam: FMX101, for the treatment of moderate-to-severe acne, and FMX102, for the treatment of impetigo. Having completed Phase II clinical trials of these product candidates, the company expects to initiate Phase III pivotal clinical trials for both in 2015 and file for subsequent U.S. regulatory approvals in 2016.

The Company collaborates with leading global pharmaceutical companies in the creation of advanced products with improved convenience, higher compliance and better efficacy, which are backed by an extensive patent portfolio. Our most advanced Rx product is currently in Phase III clinical trials.

www.finanzen.net/analyse/...als_Buy-H_C_Wainwright__Co__620683

Foamix meldet Zahlen für Q1/19

• Umsatz 0,3 Mio. $
  
• Verlust 15 Mio. $
  
• Cash 83 Mio. $
  
• MK 163 Mio. $
  

www.foamix.com/news-releases/...financial-results-and-provides

• neues 52 Wochen-Tief
  
• MK 147 Mio. $
  

• neues 52 Wochen-Tief
  
• MK 128 Mio. $
  

• neues 52 Wochen-Tief
  
• MK 114 Mio. $
  
• Q2/19 Zahlen am 8. August
  

NDA FMX101 am 20. Oktober

FDA erteilt die Zulassung für FMX101 (Amzeeq)

endpts.com/...en-acne-therapy-on-course-for-us-market-launch/

M.M.n. ein gutes Langzeit Invest mit Potential .Darüberhinaus steht im Juni 2020 das PDUFA date für eine weitere Indikation an ( Rosacea). Fomx Ist jetzt zwar schon gut gelaufen, aber mit der FDA Zulassung ist das Risko hier gut überschaubar. Vielleicht keine Rakete, aber es lohnt sich mMn hier dabei zu sein ..

Merger mit Menlo

• All-Stock-Deal
  

www.foamix.com/news-releases/...rge-creating-combined-company

seekingalpha.com/news/...eq-on-preferred-list-express-scripts